Literature DB >> 12106805

Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test.

Shuang Li1, Raymond M Quock.   

Abstract

There is controversy whether endogenous nitric oxide (NO) is involved in anxiogenesis or anxiolysis. This study was conducted to determine the influence of the NO donor, 3-morpholinosyndnonimine (SIN-1), on resting and nitrous oxide (N(2)O)-induced behaviors in the mouse light/dark exploration test. I.c.v. doses of 0.3 and 1.0 microg SIN-1 both increased the time spent in the light compartment. When pretreated with 0.1 microg SIN-1, mice responded to N(2)O with an apparent additive increase in the time spent in the light compartment. These findings further support a functional role of NO in regulation of anxiety and mediation of N(2)O-induced behavior.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106805     DOI: 10.1016/s0014-2999(02)01891-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  An anxiolytic-like effect of hyperbaric oxygen in the mouse light/dark exploration test.

Authors:  Edina L Carlile; Donald Y Shirachi; Raymond M Quock
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

2.  The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.

Authors:  Aikaterini Trevlopoulou; Ntilara Touzlatzi; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2015-12-19       Impact factor: 4.530

3.  Antagonism of nitrous oxide-induced anxiolytic-like behavior in the mouse light/dark exploration procedure by pharmacologic disruption of endogenous nitric oxide function.

Authors:  Shuang Li; Yusuke Ohgami; Yang Dai; Raymond M Quock
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

Review 4.  Advances in understanding the actions of nitrous oxide.

Authors:  Dimitris E Emmanouil; Raymond M Quock
Journal:  Anesth Prog       Date:  2007

5.  Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.

Authors:  P C M Spolidório; M B Echeverry; M Iyomasa; F S Guimarães; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2007-07-28       Impact factor: 4.530

6.  Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology.

Authors:  Mikaela K Dimick; Danielle Omrin; Bradley J MacIntosh; Rachel H B Mitchell; Daniel Riegert; Anthony Levitt; Ayal Schaffer; Susan Belo; John Iazzetta; Garfield Detzler; Mabel Choi; Stephen Choi; Beverley A Orser; Benjamin I Goldstein
Journal:  Contemp Clin Trials Commun       Date:  2020-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.